chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza B virus test, Influenza virus test negative, Intervertebral disc degeneration, Legionella test, Lung infiltration
Clinical narrative: Patient discharged- 2 day hospital inpatient 11/14-11/16/21 HOSPITAL COURSE: Patient is an 81-year-old male who was admitted on 11/14/2021 for acute on chronic hypoxic respiratory failure secondary to bacterial pneumonia and chronic obstructive pulmonary disease exacerbation.   Chronic obstructive pulmonary disease exacerbation Patient was initiated on Solu-Medrol 60 mg q.6, weaned to 40 mg and tomorrow will start prednisone 40 mg daily to then transition back to his baseline 12.5 mg on 11/19.  Continue home inhalers and DuoNebs.   Pneumonia Treated initially with Zosyn, vancomycin, and azithromycin.  I spoke with patient's pulmonologist Dr. who recommended transitioning to Cipro again for 2 week course.  We attempted to get sputum culture but even with Mucinex and saline nebulizers we were unable to get this.  There was no growth to blood cultures.  Patient's baseline O2 requirements are 2 L with activity and sleeping he has been requiring 2 L 247 while here.  Patient feels very ready to leave will have pulmonology and PCP work with him to wean back to his baseline.   COVID-19 positive test Patient's rapid was positive for COVID-19 however thought to be false positive with the late showed a due to COVID-19 infection in September 30th.  Film array was obtained and was negative for any virus.   PT/OT evaluated patient in are recommending home health.  Care Management assisting with this.  Patient's vitals are stable, he subjectively feels well.  Pulmonology team will follow-up in a couple days, patient will see Dr., Cardiology on 11/19.  With a safe discharge plan patient is medically clear for discharge.   CONSULTS / RECOMMENDATION: Pulmonology:  Cipro for 2 weeks, waiting on steroids, they will follow up closely.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Lung opacity, Mycoplasma test negative, Pneumonia bacterial, Pneumonia viral, Pulmonary fibrosis
Clinical narrative: Patient discharged- 2 day hospital inpatient 11/14-11/16/21 HOSPITAL COURSE: Patient is an 81-year-old male who was admitted on 11/14/2021 for acute on chronic hypoxic respiratory failure secondary to bacterial pneumonia and chronic obstructive pulmonary disease exacerbation.   Chronic obstructive pulmonary disease exacerbation Patient was initiated on Solu-Medrol 60 mg q.6, weaned to 40 mg and tomorrow will start prednisone 40 mg daily to then transition back to his baseline 12.5 mg on 11/19.  Continue home inhalers and DuoNebs.   Pneumonia Treated initially with Zosyn, vancomycin, and azithromycin.  I spoke with patient's pulmonologist Dr. who recommended transitioning to Cipro again for 2 week course.  We attempted to get sputum culture but even with Mucinex and saline nebulizers we were unable to get this.  There was no growth to blood cultures.  Patient's baseline O2 requirements are 2 L with activity and sleeping he has been requiring 2 L 247 while here.  Patient feels very ready to leave will have pulmonology and PCP work with him to wean back to his baseline.   COVID-19 positive test Patient's rapid was positive for COVID-19 however thought to be false positive with the late showed a due to COVID-19 infection in September 30th.  Film array was obtained and was negative for any virus.   PT/OT evaluated patient in are recommending home health.  Care Management assisting with this.  Patient's vitals are stable, he subjectively feels well.  Pulmonology team will follow-up in a couple days, patient will see Dr., Cardiology on 11/19.  With a safe discharge plan patient is medically clear for discharge.   CONSULTS / RECOMMENDATION: Pulmonology:  Cipro for 2 weeks, waiting on steroids, they will follow up closely.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary mass, Pulmonary valve thickening, Respiratory syncytial virus test negative, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: Patient discharged- 2 day hospital inpatient 11/14-11/16/21 HOSPITAL COURSE: Patient is an 81-year-old male who was admitted on 11/14/2021 for acute on chronic hypoxic respiratory failure secondary to bacterial pneumonia and chronic obstructive pulmonary disease exacerbation.   Chronic obstructive pulmonary disease exacerbation Patient was initiated on Solu-Medrol 60 mg q.6, weaned to 40 mg and tomorrow will start prednisone 40 mg daily to then transition back to his baseline 12.5 mg on 11/19.  Continue home inhalers and DuoNebs.   Pneumonia Treated initially with Zosyn, vancomycin, and azithromycin.  I spoke with patient's pulmonologist Dr. who recommended transitioning to Cipro again for 2 week course.  We attempted to get sputum culture but even with Mucinex and saline nebulizers we were unable to get this.  There was no growth to blood cultures.  Patient's baseline O2 requirements are 2 L with activity and sleeping he has been requiring 2 L 247 while here.  Patient feels very ready to leave will have pulmonology and PCP work with him to wean back to his baseline.   COVID-19 positive test Patient's rapid was positive for COVID-19 however thought to be false positive with the late showed a due to COVID-19 infection in September 30th.  Film array was obtained and was negative for any virus.   PT/OT evaluated patient in are recommending home health.  Care Management assisting with this.  Patient's vitals are stable, he subjectively feels well.  Pulmonology team will follow-up in a couple days, patient will see Dr., Cardiology on 11/19.  With a safe discharge plan patient is medically clear for discharge.   CONSULTS / RECOMMENDATION: Pulmonology:  Cipro for 2 weeks, waiting on steroids, they will follow up closely.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Scan with contrast abnormal, Streptococcus test negative, Viral test negative
Clinical narrative: Patient discharged- 2 day hospital inpatient 11/14-11/16/21 HOSPITAL COURSE: Patient is an 81-year-old male who was admitted on 11/14/2021 for acute on chronic hypoxic respiratory failure secondary to bacterial pneumonia and chronic obstructive pulmonary disease exacerbation.   Chronic obstructive pulmonary disease exacerbation Patient was initiated on Solu-Medrol 60 mg q.6, weaned to 40 mg and tomorrow will start prednisone 40 mg daily to then transition back to his baseline 12.5 mg on 11/19.  Continue home inhalers and DuoNebs.   Pneumonia Treated initially with Zosyn, vancomycin, and azithromycin.  I spoke with patient's pulmonologist Dr. who recommended transitioning to Cipro again for 2 week course.  We attempted to get sputum culture but even with Mucinex and saline nebulizers we were unable to get this.  There was no growth to blood cultures.  Patient's baseline O2 requirements are 2 L with activity and sleeping he has been requiring 2 L 247 while here.  Patient feels very ready to leave will have pulmonology and PCP work with him to wean back to his baseline.   COVID-19 positive test Patient's rapid was positive for COVID-19 however thought to be false positive with the late showed a due to COVID-19 infection in September 30th.  Film array was obtained and was negative for any virus.   PT/OT evaluated patient in are recommending home health.  Care Management assisting with this.  Patient's vitals are stable, he subjectively feels well.  Pulmonology team will follow-up in a couple days, patient will see Dr., Cardiology on 11/19.  With a safe discharge plan patient is medically clear for discharge.   CONSULTS / RECOMMENDATION: Pulmonology:  Cipro for 2 weeks, waiting on steroids, they will follow up closely.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dry eye, Eye infection, Pupil dilation procedure, Visual impairment
Clinical narrative: On 4/30/2021 I had extreme vision issues I was unable to see I was treated on 5/2/2021 for eye infections placed on 2 different eye drops since the infection returned again. My eyes still didn't get 100% better I visited another eye dr on 7/19/2021 I was diagnosed with extreme eye dryness and writteen a prescription for restasis which I will have to take daily.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis requested.  Full vaccine efficacy not shown.  Recommended that patient receive an additional vaccine.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: The nurse stated that she reconstituted the 5-11 year old  Pfizer Covid-19 vaccine with 1.8 ml of 0.9% of normal saline instead of 1.3 ml.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chills, Lethargy, Musculoskeletal stiffness, Pain
Clinical narrative: Overall body ache, chills, stiff neck, lower back pain, lethargic feeling for the entire day.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis requested.  Full vaccine efficacy not shown.  Recommended that patient receive an additional vaccine.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Aspartate aminotransferase, Blood bilirubin, Blood culture, Blood electrolytes, Blood glucose
Clinical narrative: 2/24/2021 Developed diarrhea and vomiting and later hypotensive in the evening. Went to the ER and arrived after midnight (2/25/2021) Test were done were as follows: Blood culture, BUN, Electrolytes, CBC, Lactic Acid, Prothombintine, Troponin -1, AST, Astilinphasitatse, Total Bilirubin, Glucose, Preatnin, Stool Culture, Clostridium Difficile Antigen, Sars Cov-2 Flu A&B, Chest X-Ray, CT Scan, Phosphate, Magnesium, Urinalysis, Urine culture. Treatment that was given in Antibiotics Fluid (IV).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid, Blood magnesium, Blood phosphorus, Blood urea, Chest X-ray
Clinical narrative: 2/24/2021 Developed diarrhea and vomiting and later hypotensive in the evening. Went to the ER and arrived after midnight (2/25/2021) Test were done were as follows: Blood culture, BUN, Electrolytes, CBC, Lactic Acid, Prothombintine, Troponin -1, AST, Astilinphasitatse, Total Bilirubin, Glucose, Preatnin, Stool Culture, Clostridium Difficile Antigen, Sars Cov-2 Flu A&B, Chest X-Ray, CT Scan, Phosphate, Magnesium, Urinalysis, Urine culture. Treatment that was given in Antibiotics Fluid (IV).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Clostridium test, Computerised tomogram, Culture stool, Culture urine, Diarrhoea
Clinical narrative: 2/24/2021 Developed diarrhea and vomiting and later hypotensive in the evening. Went to the ER and arrived after midnight (2/25/2021) Test were done were as follows: Blood culture, BUN, Electrolytes, CBC, Lactic Acid, Prothombintine, Troponin -1, AST, Astilinphasitatse, Total Bilirubin, Glucose, Preatnin, Stool Culture, Clostridium Difficile Antigen, Sars Cov-2 Flu A&B, Chest X-Ray, CT Scan, Phosphate, Magnesium, Urinalysis, Urine culture. Treatment that was given in Antibiotics Fluid (IV).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count, Hypotension, Influenza A virus test, Influenza B virus test, Prothrombin time
Clinical narrative: 2/24/2021 Developed diarrhea and vomiting and later hypotensive in the evening. Went to the ER and arrived after midnight (2/25/2021) Test were done were as follows: Blood culture, BUN, Electrolytes, CBC, Lactic Acid, Prothombintine, Troponin -1, AST, Astilinphasitatse, Total Bilirubin, Glucose, Preatnin, Stool Culture, Clostridium Difficile Antigen, Sars Cov-2 Flu A&B, Chest X-Ray, CT Scan, Phosphate, Magnesium, Urinalysis, Urine culture. Treatment that was given in Antibiotics Fluid (IV).
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Troponin, Urine analysis, Vomiting
Clinical narrative: 2/24/2021 Developed diarrhea and vomiting and later hypotensive in the evening. Went to the ER and arrived after midnight (2/25/2021) Test were done were as follows: Blood culture, BUN, Electrolytes, CBC, Lactic Acid, Prothombintine, Troponin -1, AST, Astilinphasitatse, Total Bilirubin, Glucose, Preatnin, Stool Culture, Clostridium Difficile Antigen, Sars Cov-2 Flu A&B, Chest X-Ray, CT Scan, Phosphate, Magnesium, Urinalysis, Urine culture. Treatment that was given in Antibiotics Fluid (IV).
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Drew up and injected adult dose into pediatric patient, no adverse outcomes according to parent, called and spoke with parent on 11/18 after identifying error.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis requested.  Full vaccine efficacy not shown.  Recommended that patient receive an additional vaccine.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Headache, Muscle spasms, Vaccination site swelling
Clinical narrative: Patient called the lab yesterday and spoke to the receptionist and the message was passed along to me.  He said that his side effects started right after the vaccine.  He complained of GI upset, headache, leg cramping and a bump at the vaccination site.  I tried calling him back twice on 11/18/21 and twice 11/19/21.  The phone went straight to VM.  I left a VM, but I have not hears back yet.  The patient told the receptionist that he was going to see his PCP that day (11/18/21).  I was unable to speak to the patient directly at the time the report was written, despite 4 attempts at calling him.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis requested.  Full vaccine efficacy not shown.  Recommended that patient receive an additional vaccine.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of consciousness
Clinical narrative: passed out
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time, Blister, Blood magnesium, Brain natriuretic peptide, Cardiac failure
Clinical narrative: 1 week onset of heart failure episode and hospitalization 2 week accelerated gout episode requiring emergency room treatment 1.5 months blistering and peeling of skin requiring over counter anti biotic ointment 1.5 months severe itching arms, legs, and body treated with aloe and cortizone cream
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray, Condition aggravated, Differential white blood cell count, Electrocardiogram, Fibrin D dimer
Clinical narrative: 1 week onset of heart failure episode and hospitalization 2 week accelerated gout episode requiring emergency room treatment 1.5 months blistering and peeling of skin requiring over counter anti biotic ointment 1.5 months severe itching arms, legs, and body treated with aloe and cortizone cream
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count, Glycosylated haemoglobin, Gout, Metabolic function test, Prothrombin time
Clinical narrative: 1 week onset of heart failure episode and hospitalization 2 week accelerated gout episode requiring emergency room treatment 1.5 months blistering and peeling of skin requiring over counter anti biotic ointment 1.5 months severe itching arms, legs, and body treated with aloe and cortizone cream
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, SARS-CoV-2 test, Skin exfoliation, Troponin
Clinical narrative: 1 week onset of heart failure episode and hospitalization 2 week accelerated gout episode requiring emergency room treatment 1.5 months blistering and peeling of skin requiring over counter anti biotic ointment 1.5 months severe itching arms, legs, and body treated with aloe and cortizone cream
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Coronary artery thrombosis, Laboratory test, Myocardial infarction
Clinical narrative: BLOOD CLOTS IN CORONARY ARTERY RESULTING IN MYOCARDIAL INFARACTION
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Stored beyond use date.  Moderna analysis requested.  Full vaccine efficacy not shown.  Recommended that patient receive an additional vaccine.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Loss of consciousness
Clinical narrative: Patient received his COVID vaccine yesterday and when he was at school today (11/19/2021) he passed out when he was on his knees and slid under the seat. He was checked by a doctor who then referred him to a Pediatric Cardiologist for evaluation. He was only unconscious for 4 seconds.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dermatitis atopic, Eczema, Rash pruritic
Clinical narrative: Started with a mild, itchy rash around 9/7/2021, progressively got itchier and spread over there next couple of weeks. I saw urgent care on 9/22, was diagnosed as atopic dermatitis, and was prescribed Prednisone for a 12 day course. Got even worse over the next few days, so I went back to urgent care who sent me to dermatology. Diagnosed as eczema, given a prescription steroid cream, and instructions on skin care. Symptoms have slowly diminished, but I still have some itching and take a non sedating antihistamine daily.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chest X-ray, SARS-CoV-2 test positive
Clinical narrative: Patient presented to ED with c/o weakness, COVID test resulted as positive,
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac monitoring, Electrocardiogram, Palpitations, Supraventricular extrasystoles, Ventricular extrasystoles
Clinical narrative: I developed palpitations after the vaccine. When I checked my pulse, it was at 150 and then dropped to the 30s. I was sent to the ER. I had an external cardiac monitor on for 7 days. It shows that I now have PAC and PVC. They wanted to admit me, but I did not want to be admitted. I was prescribed metoprolol 25mg, twice a day. I am still experiencing issues with palpitations.
Age: 38.0
Sex: F
Vaccine: FLU4
Symptoms: Hypoaesthesia, Mass, Paraesthesia
Clinical narrative: Numbness and tingling in vaccine arm and lump under collarbone
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: The nurse stated that she reconstituted the 5-11 year old  Pfizer Covid-19 vaccine with 1.8 ml of 0.9% of normal saline instead of 1.3 ml.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Computerised tomogram thorax abnormal, Dyspnoea, Echocardiogram, Pulmonary embolism
Clinical narrative: Pt developed shortness of breath. Fount to have PE. Physician feels PE could be result of vaccines since pt has no known risk factors or cause for this incident. Pt started on Xarelto since other meds contraindicated due to pt allergies.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ultrasound Doppler, X-ray
Clinical narrative: Pt developed shortness of breath. Fount to have PE. Physician feels PE could be result of vaccines since pt has no known risk factors or cause for this incident. Pt started on Xarelto since other meds contraindicated due to pt allergies.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient got the full dose (0.5mL) but they are not immunocompromised and should have only received 0.25mL. I realized my dose error while patient was still in the store. I notified the patient immediately.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Food allergy, Lacrimation increased, Lip swelling, Ocular hyperaemia, Paraesthesia oral
Clinical narrative: New onset of tree nuts allergy 9 days after receiving vaccine.   Tingling of mouth, eyes became red, itchy, and watering, vomited twice, slight swelling of lips.  Symptoms relieved with benadryl.
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: New onset of tree nuts allergy 9 days after receiving vaccine.   Tingling of mouth, eyes became red, itchy, and watering, vomited twice, slight swelling of lips.  Symptoms relieved with benadryl.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood culture negative, COVID-19, Cardiac failure acute, Cardiac failure congestive
Clinical narrative: Inpatient stay discharged after two days. 11/14-11/16/21 HOSPITAL COURSE: Pt is an 84 yo male who presented tot he ED due to AMS. He seen by his PA initially on 10/21 and diagnosed with left perihilar PNA and treated antibiotics. He followed up with his PA on 10/25 and was placed on steroid taper. He presented to the ED on 11/12 at which time CT thorax was obtained demonstrating no acute findings, but granulomatous lung changes and calcified pleural plaque suggestive of asbestos disease. He was discharged from the ED.   He returned to the ED on 11/14 with CXR demonstrating patchy alveolar infiltrates which may be representative of edema or infiltrate. Patient tested positive for COVID-19 and was admitted to the medicine service of acute hypoxic respiratory failure   # Acute Hypoxic Respiratory Failure # Acute on Chronic CHF exacerbation Felt secondary to mild CHF exacerbation, he was treated with IV lasix with quick resolution of hypoxia and able to wean to room air. He reported his dry weight to be 220 lbs with discharge standing weight being 98.6 kg (217 lb). Patient desired to discharge and not want to be monitored for 24 hours on resumption of his home oral lasix. He was instructed to monitor weight daily and maintain a 2 liter fluid restriction.    # COVID-19 Patient weaned to room air after lasix administration and given lack of findings suggestive COVID-19 on initial imaging, decadron was not given while hospitalized. Did receive dose in the ED. Patient was also noted to be vaccinated with J&J vaccine.    # Abnormal CT of the Chest Pulmonary was consulted given findings on chest CT and recommended outpatient follow-up with no additional workup while hospitalized.    Although patient did not reports any dyspnea with ambulation, he was noted to have oxygen saturation <88% at times while ambulating. Given his desire to discharge without further attempts to wean with IV lasix, pulmonary rehab was consulted an patient was discharged on 2 liters of oxygen via NC with activity. Patient was discharged home in stable condition with discharge instructions provided.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Computerised tomogram thorax abnormal, Dyspnoea, Lung infiltration, Lung opacity
Clinical narrative: Inpatient stay discharged after two days. 11/14-11/16/21 HOSPITAL COURSE: Pt is an 84 yo male who presented tot he ED due to AMS. He seen by his PA initially on 10/21 and diagnosed with left perihilar PNA and treated antibiotics. He followed up with his PA on 10/25 and was placed on steroid taper. He presented to the ED on 11/12 at which time CT thorax was obtained demonstrating no acute findings, but granulomatous lung changes and calcified pleural plaque suggestive of asbestos disease. He was discharged from the ED.   He returned to the ED on 11/14 with CXR demonstrating patchy alveolar infiltrates which may be representative of edema or infiltrate. Patient tested positive for COVID-19 and was admitted to the medicine service of acute hypoxic respiratory failure   # Acute Hypoxic Respiratory Failure # Acute on Chronic CHF exacerbation Felt secondary to mild CHF exacerbation, he was treated with IV lasix with quick resolution of hypoxia and able to wean to room air. He reported his dry weight to be 220 lbs with discharge standing weight being 98.6 kg (217 lb). Patient desired to discharge and not want to be monitored for 24 hours on resumption of his home oral lasix. He was instructed to monitor weight daily and maintain a 2 liter fluid restriction.    # COVID-19 Patient weaned to room air after lasix administration and given lack of findings suggestive COVID-19 on initial imaging, decadron was not given while hospitalized. Did receive dose in the ED. Patient was also noted to be vaccinated with J&J vaccine.    # Abnormal CT of the Chest Pulmonary was consulted given findings on chest CT and recommended outpatient follow-up with no additional workup while hospitalized.    Although patient did not reports any dyspnea with ambulation, he was noted to have oxygen saturation <88% at times while ambulating. Given his desire to discharge without further attempts to wean with IV lasix, pulmonary rehab was consulted an patient was discharged on 2 liters of oxygen via NC with activity. Patient was discharged home in stable condition with discharge instructions provided.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Mental status changes, Pleural calcification, Pleural fibrosis, Pneumonia, Pulmonary oedema
Clinical narrative: Inpatient stay discharged after two days. 11/14-11/16/21 HOSPITAL COURSE: Pt is an 84 yo male who presented tot he ED due to AMS. He seen by his PA initially on 10/21 and diagnosed with left perihilar PNA and treated antibiotics. He followed up with his PA on 10/25 and was placed on steroid taper. He presented to the ED on 11/12 at which time CT thorax was obtained demonstrating no acute findings, but granulomatous lung changes and calcified pleural plaque suggestive of asbestos disease. He was discharged from the ED.   He returned to the ED on 11/14 with CXR demonstrating patchy alveolar infiltrates which may be representative of edema or infiltrate. Patient tested positive for COVID-19 and was admitted to the medicine service of acute hypoxic respiratory failure   # Acute Hypoxic Respiratory Failure # Acute on Chronic CHF exacerbation Felt secondary to mild CHF exacerbation, he was treated with IV lasix with quick resolution of hypoxia and able to wean to room air. He reported his dry weight to be 220 lbs with discharge standing weight being 98.6 kg (217 lb). Patient desired to discharge and not want to be monitored for 24 hours on resumption of his home oral lasix. He was instructed to monitor weight daily and maintain a 2 liter fluid restriction.    # COVID-19 Patient weaned to room air after lasix administration and given lack of findings suggestive COVID-19 on initial imaging, decadron was not given while hospitalized. Did receive dose in the ED. Patient was also noted to be vaccinated with J&J vaccine.    # Abnormal CT of the Chest Pulmonary was consulted given findings on chest CT and recommended outpatient follow-up with no additional workup while hospitalized.    Although patient did not reports any dyspnea with ambulation, he was noted to have oxygen saturation <88% at times while ambulating. Given his desire to discharge without further attempts to wean with IV lasix, pulmonary rehab was consulted an patient was discharged on 2 liters of oxygen via NC with activity. Patient was discharged home in stable condition with discharge instructions provided.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Inpatient stay discharged after two days. 11/14-11/16/21 HOSPITAL COURSE: Pt is an 84 yo male who presented tot he ED due to AMS. He seen by his PA initially on 10/21 and diagnosed with left perihilar PNA and treated antibiotics. He followed up with his PA on 10/25 and was placed on steroid taper. He presented to the ED on 11/12 at which time CT thorax was obtained demonstrating no acute findings, but granulomatous lung changes and calcified pleural plaque suggestive of asbestos disease. He was discharged from the ED.   He returned to the ED on 11/14 with CXR demonstrating patchy alveolar infiltrates which may be representative of edema or infiltrate. Patient tested positive for COVID-19 and was admitted to the medicine service of acute hypoxic respiratory failure   # Acute Hypoxic Respiratory Failure # Acute on Chronic CHF exacerbation Felt secondary to mild CHF exacerbation, he was treated with IV lasix with quick resolution of hypoxia and able to wean to room air. He reported his dry weight to be 220 lbs with discharge standing weight being 98.6 kg (217 lb). Patient desired to discharge and not want to be monitored for 24 hours on resumption of his home oral lasix. He was instructed to monitor weight daily and maintain a 2 liter fluid restriction.    # COVID-19 Patient weaned to room air after lasix administration and given lack of findings suggestive COVID-19 on initial imaging, decadron was not given while hospitalized. Did receive dose in the ED. Patient was also noted to be vaccinated with J&J vaccine.    # Abnormal CT of the Chest Pulmonary was consulted given findings on chest CT and recommended outpatient follow-up with no additional workup while hospitalized.    Although patient did not reports any dyspnea with ambulation, he was noted to have oxygen saturation <88% at times while ambulating. Given his desire to discharge without further attempts to wean with IV lasix, pulmonary rehab was consulted an patient was discharged on 2 liters of oxygen via NC with activity. Patient was discharged home in stable condition with discharge instructions provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: LIGHT HEADED AND DIZZY AFTER THE SHOT
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Constant headache, pain level 3/10 daily since the vaccine booster.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphonia, Pruritus, Throat irritation
Clinical narrative: Patient given 2nd dose of Pfizer vaccine at 1222.  She complained of generalized itching at 1233.  Her voice became raspy and complained of itching in the throat.  No complain of SOB or chest spin.  Epi-Pen was administered in left thigh.  Patient transported to ED via wheelchair  methylPREDNISolone Sod Succ (PF) Inj 125 mg (SOLU-Medrol PF)  ? diphenhydrAMINE Inj 25 mg (BENADRYL) ? Sodium Chloride 0.9 % IV Bolus ? Famotidine (PF) Inj 20 mg (PEPCID) ? predniSONE (ORASONE) 20 mg Oral Tab ? diphenhydrAMINE (BENADRYL) 25 mg Oral Cap
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Hypoaesthesia, Palpitations
Clinical narrative: After 2nd Dose 2 weeks later  Numbness in Arms Chest Pain, Short of Breath, Heart Racing
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: The nurse stated that she reconstituted the 5-11 year old  Pfizer Covid-19 vaccine with 1.8 ml of 0.9% of normal saline instead of 1.3 ml.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: On cdc checklist pt states they are immunocompromised and should have received a 0.5ml dose but instead received 0.25ml.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Oropharyngeal pain, Pruritus
Clinical narrative: Client was vaccinated at 14:29. Around 1440 the observation nurse noted that the client was fanning himself. The client complained that he was feeling hot, Right arm and leg pruritus, new "throat pain" and dizziness. The observation nurse and POD lead then called emergency services at 1445 and initiated the anaphylaxis protocol. An epipen JR was administered (Lot # LFN341) IM to right thigh at 1451 and at 1457 0.4ml of Diphenhydramine (lot # 080008) was administered IM to R Deltoid by Nurse. EMS arrived at 1458 and hand off occurred to the crew at 1459. Transport to local Medical Center ER occurred at 1505.
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Nasal congestion, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: 11/19/21-He is fairly healthy for his age, has chronic allergies with allergic rhinitis, worked a day before his symptom onset in his front yard, raking the leaves with mask on.      URI The primary symptoms include nasal congestion and nasal drainage. Primary symptoms do not include fever, headaches, sore throat, cough, wheezing, myalgias or shortness of breath. The current episode started 3 to 5 days ago (4 days). This is a new problem. The problem has not changed since onset. Symptoms associated with the illness include congestion and rhinorrhea. The illness is not associated with chills.  Physical Exam  11/19/21 Vitals and nursing note reviewed.  Constitutional:      General: He is not in acute distress.    Appearance: He is well-developed. He is not diaphoretic.  HENT:     Right Ear: Tympanic membrane and ear canal normal. Decreased hearing noted.     Left Ear: Ear canal normal.     Ears:     Comments: Hearing aid in right ear noted.     Nose: Congestion and rhinorrhea present.     Right Sinus: No maxillary sinus tenderness or frontal sinus tenderness.     Left Sinus: No maxillary sinus tenderness or frontal sinus tenderness.     Mouth/Throat:     Mouth: Mucous membranes are moist.     Pharynx: No posterior oropharyngeal erythema.     Tonsils: No tonsillar exudate.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Heart sounds: Normal heart sounds. No murmur heard. Pulmonary:     Effort: Pulmonary effort is normal.     Breath sounds: Normal breath sounds. No wheezing.  Musculoskeletal:        General: No deformity. Normal range of motion.  Lymphadenopathy:     Cervical: No cervical adenopathy.  Neurological:     Mental Status: He is alert and oriented to person, place, and time.     Coordination: Coordination normal.  Psychiatric:        Behavior: Behavior normal.   11/19/21-Discussed the lab findings with him, he is referred for Regeneron infusion.  Rest, fluids and other supportive care including supplements (Vit C, Vit D, Zn) and OTC med prn for symptom relief discussed, expected course of illness and recovery time discussed. CDC guidelines for self quarantine and timeframe for RTW
Age: 84.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Upper respiratory tract infection
Clinical narrative: 11/19/21-He is fairly healthy for his age, has chronic allergies with allergic rhinitis, worked a day before his symptom onset in his front yard, raking the leaves with mask on.      URI The primary symptoms include nasal congestion and nasal drainage. Primary symptoms do not include fever, headaches, sore throat, cough, wheezing, myalgias or shortness of breath. The current episode started 3 to 5 days ago (4 days). This is a new problem. The problem has not changed since onset. Symptoms associated with the illness include congestion and rhinorrhea. The illness is not associated with chills.  Physical Exam  11/19/21 Vitals and nursing note reviewed.  Constitutional:      General: He is not in acute distress.    Appearance: He is well-developed. He is not diaphoretic.  HENT:     Right Ear: Tympanic membrane and ear canal normal. Decreased hearing noted.     Left Ear: Ear canal normal.     Ears:     Comments: Hearing aid in right ear noted.     Nose: Congestion and rhinorrhea present.     Right Sinus: No maxillary sinus tenderness or frontal sinus tenderness.     Left Sinus: No maxillary sinus tenderness or frontal sinus tenderness.     Mouth/Throat:     Mouth: Mucous membranes are moist.     Pharynx: No posterior oropharyngeal erythema.     Tonsils: No tonsillar exudate.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Heart sounds: Normal heart sounds. No murmur heard. Pulmonary:     Effort: Pulmonary effort is normal.     Breath sounds: Normal breath sounds. No wheezing.  Musculoskeletal:        General: No deformity. Normal range of motion.  Lymphadenopathy:     Cervical: No cervical adenopathy.  Neurological:     Mental Status: He is alert and oriented to person, place, and time.     Coordination: Coordination normal.  Psychiatric:        Behavior: Behavior normal.   11/19/21-Discussed the lab findings with him, he is referred for Regeneron infusion.  Rest, fluids and other supportive care including supplements (Vit C, Vit D, Zn) and OTC med prn for symptom relief discussed, expected course of illness and recovery time discussed. CDC guidelines for self quarantine and timeframe for RTW
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Heart rate abnormal, Nasopharyngitis, Palpitations
Clinical narrative: I started having palpitations, my heart rate felt like a hiccup with my heart. That was in the beginning of April. It kept happening for like 10 days. I scheduled a visit with a doctor. My visit was on 04/19/2021 and they did blood work, which came back normal. I usually track my water intake and I was not dehydrated. Also, I did not over exercise. The week before the palpitations started, I had a cold.  On 04/22/2021 I stopped having the palpitations.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine administered on 11/12/2021, expiration date was 11/7/202.  Mistook expiration date to be 11/17/2021.  No adverse event or outcome to recipient.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Pt recieved second dose of pfizer covid vaccine a week early. Initial dose was given on 11/5/21, second dose was given on 11/19/21
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect route of product administration
Clinical narrative: Patient and mother were sitting at Doctor's vaccine station to receive dose 1 of the Pfizer pediatric COVID vaccine (lot FK5127) at approximately 1130. The patient was struggling to get out of his mother's hold. Nurse approached to assist vaccinator in educating parent on proper hold for children. Nurse went to vaccinate the patient who moved. Nurse punctured the patient's skin then withdrew the needle without administering any vaccine. Nurse educated mother on safest hold for pediatrics. Nurse administered dose 1 of the Pfizer pediatric COVID vaccine (lot FK5127) at 1135.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Injection site pain, Pain
Clinical narrative: Pain in arm at injection sight. Elevated temperature. Full body aches.
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Gait inability
Clinical narrative: couldn't walk, effected his back, took a week to get over it.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Acquired diaphragmatic eventration, Back pain, Blood lactic acid increased, Blood phosphorus increased, Blood potassium increased
Clinical narrative: Currently admitted - 11/14/21 to present 11/19/2021 ( 5 days)  PT is a 71 y.o. female known ESRD on HD who is a resident from  facility for many years presented to  emergency department for altered mental status.  Patient tested positive for COVID-19 on 11/12/21.  Patient is alert and oriented to herself.  Upon emergency department arrival, vital signs are overall stable.  Patient noted to have a cellulitis of bilateral lower extremity which patient is receiving penicillin.  Workups at emergency department, complete blood count without leukocytosis, UA with pyuria but negative nitrite, lactic acid elevated at 2.5, CMP with elevated potassium and phosphorus without EKG changes.  There is also hyponatremia.  Chest x-ray showed COVID-19 pneumonia.  During stay at emergency department patient had hypoxic event 81%, acquiring 3 L nasal cannula oxygen support.  Patient being transferred here due to need of hemodialysis.  PT is a 71 y.o.  female who is seen in consultation for a history of end-stage kidney disease. She typically dialyzes at on a MWF schedule. She uses a left forearm brachiobasilic loop graft for dialysis access, and has an estimated dry weight of 64.5 kg.  The patient was taken to the emergency department at  Hospital for altered mental status.  The patient was found to have cellulitis of her lower extremities.  Labs demonstrated elevated potassium and phosphorus and hyponatremia.  Chest x-ray was consistent with COVID-19 pneumonia, the patient had previously tested positive on 11/12.   When seen, the patient endorses chronic back pain, which is unchanged. She denies fevers, chills, nausea, emesis, headaches, visual changes, tinnitus, epistaxis, oral ulcers, sore throat, chest pain, shortness of breath at rest, dyspnea on exertion, cough, wheeze, orthopnea, paroxysmal nocturnal dyspnea, abdominal pain, diarrhea, hematochezia, melena, rash, and pruritus.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cellulitis, Chest X-ray abnormal, Electrocardiogram normal
Clinical narrative: Currently admitted - 11/14/21 to present 11/19/2021 ( 5 days)  PT is a 71 y.o. female known ESRD on HD who is a resident from  facility for many years presented to  emergency department for altered mental status.  Patient tested positive for COVID-19 on 11/12/21.  Patient is alert and oriented to herself.  Upon emergency department arrival, vital signs are overall stable.  Patient noted to have a cellulitis of bilateral lower extremity which patient is receiving penicillin.  Workups at emergency department, complete blood count without leukocytosis, UA with pyuria but negative nitrite, lactic acid elevated at 2.5, CMP with elevated potassium and phosphorus without EKG changes.  There is also hyponatremia.  Chest x-ray showed COVID-19 pneumonia.  During stay at emergency department patient had hypoxic event 81%, acquiring 3 L nasal cannula oxygen support.  Patient being transferred here due to need of hemodialysis.  PT is a 71 y.o.  female who is seen in consultation for a history of end-stage kidney disease. She typically dialyzes at on a MWF schedule. She uses a left forearm brachiobasilic loop graft for dialysis access, and has an estimated dry weight of 64.5 kg.  The patient was taken to the emergency department at  Hospital for altered mental status.  The patient was found to have cellulitis of her lower extremities.  Labs demonstrated elevated potassium and phosphorus and hyponatremia.  Chest x-ray was consistent with COVID-19 pneumonia, the patient had previously tested positive on 11/12.   When seen, the patient endorses chronic back pain, which is unchanged. She denies fevers, chills, nausea, emesis, headaches, visual changes, tinnitus, epistaxis, oral ulcers, sore throat, chest pain, shortness of breath at rest, dyspnea on exertion, cough, wheeze, orthopnea, paroxysmal nocturnal dyspnea, abdominal pain, diarrhea, hematochezia, melena, rash, and pruritus.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Hyponatraemia, Hypoxia, Lung disorder, Mental status changes
Clinical narrative: Currently admitted - 11/14/21 to present 11/19/2021 ( 5 days)  PT is a 71 y.o. female known ESRD on HD who is a resident from  facility for many years presented to  emergency department for altered mental status.  Patient tested positive for COVID-19 on 11/12/21.  Patient is alert and oriented to herself.  Upon emergency department arrival, vital signs are overall stable.  Patient noted to have a cellulitis of bilateral lower extremity which patient is receiving penicillin.  Workups at emergency department, complete blood count without leukocytosis, UA with pyuria but negative nitrite, lactic acid elevated at 2.5, CMP with elevated potassium and phosphorus without EKG changes.  There is also hyponatremia.  Chest x-ray showed COVID-19 pneumonia.  During stay at emergency department patient had hypoxic event 81%, acquiring 3 L nasal cannula oxygen support.  Patient being transferred here due to need of hemodialysis.  PT is a 71 y.o.  female who is seen in consultation for a history of end-stage kidney disease. She typically dialyzes at on a MWF schedule. She uses a left forearm brachiobasilic loop graft for dialysis access, and has an estimated dry weight of 64.5 kg.  The patient was taken to the emergency department at  Hospital for altered mental status.  The patient was found to have cellulitis of her lower extremities.  Labs demonstrated elevated potassium and phosphorus and hyponatremia.  Chest x-ray was consistent with COVID-19 pneumonia, the patient had previously tested positive on 11/12.   When seen, the patient endorses chronic back pain, which is unchanged. She denies fevers, chills, nausea, emesis, headaches, visual changes, tinnitus, epistaxis, oral ulcers, sore throat, chest pain, shortness of breath at rest, dyspnea on exertion, cough, wheeze, orthopnea, paroxysmal nocturnal dyspnea, abdominal pain, diarrhea, hematochezia, melena, rash, and pruritus.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test abnormal, Nitrite urine absent, Pyuria, SARS-CoV-2 test positive, Urine analysis abnormal
Clinical narrative: Currently admitted - 11/14/21 to present 11/19/2021 ( 5 days)  PT is a 71 y.o. female known ESRD on HD who is a resident from  facility for many years presented to  emergency department for altered mental status.  Patient tested positive for COVID-19 on 11/12/21.  Patient is alert and oriented to herself.  Upon emergency department arrival, vital signs are overall stable.  Patient noted to have a cellulitis of bilateral lower extremity which patient is receiving penicillin.  Workups at emergency department, complete blood count without leukocytosis, UA with pyuria but negative nitrite, lactic acid elevated at 2.5, CMP with elevated potassium and phosphorus without EKG changes.  There is also hyponatremia.  Chest x-ray showed COVID-19 pneumonia.  During stay at emergency department patient had hypoxic event 81%, acquiring 3 L nasal cannula oxygen support.  Patient being transferred here due to need of hemodialysis.  PT is a 71 y.o.  female who is seen in consultation for a history of end-stage kidney disease. She typically dialyzes at on a MWF schedule. She uses a left forearm brachiobasilic loop graft for dialysis access, and has an estimated dry weight of 64.5 kg.  The patient was taken to the emergency department at  Hospital for altered mental status.  The patient was found to have cellulitis of her lower extremities.  Labs demonstrated elevated potassium and phosphorus and hyponatremia.  Chest x-ray was consistent with COVID-19 pneumonia, the patient had previously tested positive on 11/12.   When seen, the patient endorses chronic back pain, which is unchanged. She denies fevers, chills, nausea, emesis, headaches, visual changes, tinnitus, epistaxis, oral ulcers, sore throat, chest pain, shortness of breath at rest, dyspnea on exertion, cough, wheeze, orthopnea, paroxysmal nocturnal dyspnea, abdominal pain, diarrhea, hematochezia, melena, rash, and pruritus.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Movement disorder, Sinus congestion
Clinical narrative: That night - no symptoms next morning - felt he could not move his legs, very wobbly, could not get to the bathroom lasted 2-3 days also next morning - headache intense at first, now dull also next morning L sided sinus congestion that persists also next morning joint pain especially R shoulder flared - persists
Age: 11.0
Sex: M
Vaccine: FLUA4
Symptoms: Product selection error
Clinical narrative: Medical Assistant chose incorrect vaccine from Accuvax, unfamiliar with differences between 65+ flu vaccine and pediatric dose usually given (flulaval or fluzone). No treatment has been given yet.
Age: 50.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Pain
Clinical narrative: Chills, shivering, soreness, body aches, tiredness
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccine administered on 11/12/2021, expiration date was 11/7/202.  Mistook expiration date to be 11/17/2021.  No adverse event or outcome to recipient.
Age: 9.0
Sex: F
Vaccine: FLU4
Symptoms: Facial paralysis, Ophthalmoplegia
Clinical narrative: On 11/13/2021, patient went to ER for Left eye not shutting all the way, and for left facial drooping with smiling - per mom, started in the morning when patient woke up.
Age: 11.0
Sex: F
Vaccine: COVID19, FLU4, HPV9, MNQ
Symptoms: Dizziness, Headache
Clinical narrative: Dizziness, headache about 15 mins after vaccine administration. Had pt lay down, gave some apple juice. Pt reported having not eaten yet this morning. Vitals: BP 94/63, P 109, R 20, SPO2 97% RA. Pt assessed by Doctor. Pt started to feel better about 10 mins after lying down and given apple juice.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Chills, Dyspnoea, Headache
Clinical narrative: Patient to the ER on 11/17/2021 with symptoms of COVID19 Reported fever (up to 101.3F) and chills, shortness of breath, decreased oral intake (no loss of taste or smell though).  Also, reported headache.  No sore throat, no congestion, no wheezing, no chest pain, no vomiting and no diarrhea
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypophagia, Lung infiltration, Lung opacity, Malaise, Pyrexia
Clinical narrative: Patient to the ER on 11/17/2021 with symptoms of COVID19 Reported fever (up to 101.3F) and chills, shortness of breath, decreased oral intake (no loss of taste or smell though).  Also, reported headache.  No sore throat, no congestion, no wheezing, no chest pain, no vomiting and no diarrhea